BioHealth News
Keynotes and Presenters Drive the Conversation at BioHealth Capital Region Forum
The 10th Annual BioHealth Capital Region Forum has once again brought together some of the most influential leaders and innovators in the biohealth industry.…
Read More
Fast Company: Johns Hopkins Technology Ventures proves you don’t need to move to a tech hub. Just build your own
The commercialization and technology transfer arm of the storied Baltimore university is helping to foster the region’s burgeoning tech scene. BY Steven Melendez Attracting early-stage…
Read More
Virginia Governor Glenn Youngkin Honored as BIO’s Governor of the Year at BioHealth Capital Region Forum
During the opening day of the BioHealth Capital Region Forum at US Pharmacopeia in Rockville on September 17th, 2024, Virginia Governor Glenn Youngkin was…
Read More
Montgomery County Executive Marc Elrich Returns to the 10th Annual BioHealth Capital Region Forum, Celebrating a Decade of Innovation
Montgomery County Executive Marc Elrich helped kick off the 10th Annual BioHealth Capital Region Forum once again this year, reinforcing the county’s pivotal role…
Read More
NIH awards $27M to establish new network of genomics-enabled learning health systems
Network will analyze and improve how genomic information is integrated into patient care. The National Institutes of Health (NIH) is awarding $5.4 million in…
Read More
VerImmune Completes $4.5 Million First Closing of Pre-Series A Financing, Strengthens Board with Two Accomplished Biotechnology Executives
BETHESDA, Md. and SINGAPORE, Sept. 23, 2024 /PRNewswire/ -- VerImmune Inc., ("VerImmune"), a venture-backed biotechnology company developing a groundbreaking Virus-inspired Particle (ViP™) platform technology, today announced the successful…
Read More
2024 Women’s Health Innovation Summit: Leading the Future of Women’s Healthcare
The 2024 Women’s Health Innovation Summit USA taking place from September 23-25, 2024, in Boston, MA. This event will serve as a leading platform…
Read More
Leadership and Innovation Take the Stage at 10th Annual BioHealth Capital Region Week 2024
Day 1 Recap: A Dynamic Start to the 10th Annual BioHealth Capital Region Forum The 10th Annual BioHealth Capital Region Forum kicked off with…
Read More
Immobazyme Travels from South Africa to Compete in the Crab Trap at BioHealth Capital Region Week 2024
BioHealth Capital Region Week 2024 welcomed Immobazyme, a biotech company from Stellenbosch, South Africa, to compete in the 9th Annual Crab Trap Competition. Specializing…
Read More
Linshom Medical Wins 9th Annual Crab Trap Competition at BioHealth Capital Region Week
Linshom Medical, a TEDCO-backed company, located in Baltimore, MD, was named the winner of the 9th Annual Crab Trap Competition during the BioHealth Capital…
Read More
BioHealth Innovation, Inc. and Georgetown University’s Office of Technology Commercialization Collaborate to Advance Venture Creation and Research Translation
ROCKVILLE, MARYLAND, September 23, 2024 – BioHealth Innovation, Inc. (BHI) and Georgetown University’s Office of Technology Commercialization (OTC) have entered into a strategic collaboration…
Read More
TEDCO Invests in CarrTech Corp.
This biotechnology company aims to save lives through their transformative medical device. COLUMBIA, Md., (September 23, 2024) — TEDCO, Maryland’s economic engine for technology…
Read More
AstraZeneca’s FluMist approved for self-administration in the US
WILMINGTON, Del., September 20, 2024 – FLUMIST® has been approved in the US as the only self-administered influenza vaccine. FLUMIST, a needle-free nasal spray,…
Read More
USP Seeks Expert Volunteers for the 2025-2030 Cycle
U.S. Pharmacopeia (USP) is currently seeking Expert Volunteers from diverse professional backgrounds to contribute to its vital mission of safeguarding the quality of medicines,…
Read More
MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic Diseases
ROCKVILLE, Md. and SOUTH SAN FRANCISCO, Calif., Sept. 15, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing…
Read More